Literature DB >> 24744051

IL-2/CD40-activated macrophages rescue age and tumor-induced T cell dysfunction in elderly mice.

C Jackaman1, D E Dye, D J Nelson.   

Abstract

The role of macrophages and their interactions with T cells during aging is not well understood. We determined if activating elderly-derived macrophages could rescue age-related and tumor-induced T cell dysfunction. Healthy elderly (18-24 months) Balb/c contained significantly more splenic IL-10-secreting M2-macrophages and myeloid-derived suppressor cells than young (6-8 weeks) mice. Exposure to syngeneic mesothelioma or lung carcinoma-conditioned media polarized peritoneal macrophages into suppressive M2-macrophages regardless of age. Tumor-exposed, elderly, but not young-derived, macrophages produced high levels of IL-4 and could not induce T cell IFN-γ production. We attempted to rescue tumor-exposed macrophages with LPS/IFN-γ (M1 stimulus) or IL-2/agonist anti-CD40 antibody. Tumor-exposed, M1-stimulated macrophages retained high CD40 expression, yet TNF-α and IFN-γ production were diminished relative to non-tumor-exposed, M1-stimulated controls. These macrophages induced young and elderly-derived T cell proliferation however, T cells did not secrete IFN-γ. In contrast, tumor-exposed, IL-2/CD40-stimulated macrophages rescued elderly-derived T cell IFN-γ production, suggesting that IL-2/CD40-activated macrophages could rescue T cell immunity in aging hosts.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24744051      PMCID: PMC4082580          DOI: 10.1007/s11357-014-9655-y

Source DB:  PubMed          Journal:  Age (Dordr)        ISSN: 0161-9152


  45 in total

Review 1.  Potential role of immunosenescence in cancer development.

Authors:  Tamas Fulop; Rami Kotb; Carl F Fortin; Graham Pawelec; Flavia de Angelis; Anis Larbi
Journal:  Ann N Y Acad Sci       Date:  2010-06       Impact factor: 5.691

2.  Antigen-specific Treg impair CD8(+) T-cell priming by blocking early T-cell expansion.

Authors:  Pascal Chappert; Marylène Leboeuf; Philippe Rameau; Mélanie Lalfer; Sabine Desbois; Roland S Liblau; Olivier Danos; Jean M Davoust; David-Alexandre Gross
Journal:  Eur J Immunol       Date:  2010-02       Impact factor: 5.532

3.  Aging enhances the production of reactive oxygen species and bactericidal activity in peritoneal macrophages by upregulating classical activation pathways.

Authors:  Heather S Smallwood; Daniel López-Ferrer; Thomas C Squier
Journal:  Biochemistry       Date:  2011-10-19       Impact factor: 3.162

4.  Monocyte chemoattractant protein-1 blockade inhibits lung cancer tumor growth by altering macrophage phenotype and activating CD8+ cells.

Authors:  Zvi G Fridlender; Veena Kapoor; George Buchlis; Guanjun Cheng; Jing Sun; Liang-Chuan S Wang; Sunil Singhal; Linda A Snyder; Steven M Albelda
Journal:  Am J Respir Cell Mol Biol       Date:  2010-04-15       Impact factor: 6.914

5.  In aged mice, outgrowth of intraocular melanoma depends on proangiogenic M2-type macrophages.

Authors:  Long V Ly; Aabed Baghat; Mieke Versluis; Ekaterina S Jordanova; Gregorius P M Luyten; Nico van Rooijen; Thorbald van Hall; Pieter A van der Velden; Martine J Jager
Journal:  J Immunol       Date:  2010-08-16       Impact factor: 5.422

6.  Circulating and tumor-infiltrating myeloid cells predict survival in human pleural mesothelioma.

Authors:  Bryan M Burt; Scott J Rodig; Tamara R Tilleman; Andrew W Elbardissi; Raphael Bueno; David J Sugarbaker
Journal:  Cancer       Date:  2011-04-26       Impact factor: 6.860

7.  Aging in inbred strains of mice: study design and interim report on median lifespans and circulating IGF1 levels.

Authors:  Rong Yuan; Shirng-Wern Tsaih; Stefka B Petkova; Caralina Marin de Evsikova; Shuqin Xing; Michael A Marion; Molly A Bogue; Kevin D Mills; Luanne L Peters; Carol J Bult; Clifford J Rosen; John P Sundberg; David E Harrison; Gary A Churchill; Beverly Paigen
Journal:  Aging Cell       Date:  2009-04-09       Impact factor: 9.304

8.  IL-2 intratumoral immunotherapy enhances CD8+ T cells that mediate destruction of tumor cells and tumor-associated vasculature: a novel mechanism for IL-2.

Authors:  Connie Jackaman; Christine S Bundell; Beverley F Kinnear; Alison M Smith; Pierre Filion; Deborah van Hagen; Bruce W S Robinson; Delia J Nelson
Journal:  J Immunol       Date:  2003-11-15       Impact factor: 5.422

9.  Local effector failure in mesothelioma is not mediated by CD4+ CD25+ T-regulator cells.

Authors:  C Jackaman; S Cornwall; A M Lew; Y Zhan; B W S Robinson; D J Nelson
Journal:  Eur Respir J       Date:  2009-02-27       Impact factor: 16.671

Review 10.  Effects of aging on T cell function.

Authors:  Laura Haynes; Alexander C Maue
Journal:  Curr Opin Immunol       Date:  2009-06-06       Impact factor: 7.486

View more
  7 in total

1.  Murine mesothelioma induces locally-proliferating IL-10(+)TNF-α(+)CD206(-)CX3CR1(+) M3 macrophages that can be selectively depleted by chemotherapy or immunotherapy.

Authors:  Connie Jackaman; Teong L Yeoh; Manyual L Acuil; Joanne K Gardner; Delia J Nelson
Journal:  Oncoimmunology       Date:  2016-04-22       Impact factor: 8.110

Review 2.  Considerations for successful cancer immunotherapy in aged hosts.

Authors:  V Hurez; Á S Padrón; R S Svatek; T J Curiel
Journal:  Clin Exp Immunol       Date:  2016-11-07       Impact factor: 4.330

3.  Aging and immunotherapies: New horizons for the golden ages.

Authors:  Jamie A G Hamilton; Curtis J Henry
Journal:  Aging Cancer       Date:  2020-09-30

4.  Comparisons of Metastatic Patterns, Survival Outcomes and Tumor Immune Microenvironment Between Young and Non-Young Breast Cancer Patients.

Authors:  Hengwen Sun; Wei Huang; Fei Ji; Yi Pan; Lu Yang
Journal:  Front Cell Dev Biol       Date:  2022-07-14

5.  Octogenarians' Breast Cancer Is Associated with an Unfavorable Tumor Immune Microenvironment and Worse Disease-Free Survival.

Authors:  Maiko Okano; Masanori Oshi; Swagoto Mukhopadhyay; Qianya Qi; Li Yan; Itaru Endo; Toru Ohtake; Kazuaki Takabe
Journal:  Cancers (Basel)       Date:  2021-06-11       Impact factor: 6.639

6.  Macrophage Depletion in Elderly Mice Improves Response to Tumor Immunotherapy, Increases Anti-tumor T Cell Activity and Reduces Treatment-Induced Cachexia.

Authors:  Lelinh Duong; Hannah G Radley-Crabb; Joanne K Gardner; Federica Tomay; Danielle E Dye; Miranda D Grounds; Fiona J Pixley; Delia J Nelson; Connie Jackaman
Journal:  Front Genet       Date:  2018-11-06       Impact factor: 4.599

7.  Immune checkpoint protein VSIG4 as a biomarker of aging in murine adipose tissue.

Authors:  Brandon M Hall; Anatoli S Gleiberman; Evguenia Strom; Peter A Krasnov; David Frescas; Slavoljub Vujcic; Olga V Leontieva; Marina P Antoch; Valeria Kogan; Igor E Koman; Yi Zhu; Tamara Tchkonia; James L Kirkland; Olga B Chernova; Andrei V Gudkov
Journal:  Aging Cell       Date:  2020-08-28       Impact factor: 9.304

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.